645 SUMMER STREET, BOSTON, MA
Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook
Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors
Appoints Christopher D. Brown to its Board of Directors
Submission of Matters to a Vote of Security Holders
Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
Annual Report to Security Holders
Amended material disclosure
Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(4)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership
Specialized Disclosure Report